Breaking News Instant updates and real-time market news.

2020-11-18 09:25:00 AMZN Amazon.com $3,136.01 / +6.19 (+0.20%) 09:25 11/18/20 11/18 09:25 11/18/20 09:25	Jefferies software/pharma analysts hold analyst/industry conference call Software & Internet Analyst Thill and Healthcare Analyst Tanquilut discuss Amazon's move into the Pharmaceuticals Industry on an Analyst/Industry conference call to be held on November 18 at 10 am.	18 Nov 18 Nov
AMZN Amazon.com $3,136.01 / +6.19 (+0.20%) 11/18/20 Jefferies Drug distributors' pullback on Amazon news an overreaction, says Jefferies 11/18/20 Bernstein PBMs to feel pressure to add Amazon as in-network option, says Bernstein 11/18/20 RBC Capital Walmart price target raised to $153 from $137 at RBC Capital 11/18/20 Deutsche Bank GoodRx price target lowered to $31 from $50 at Deutsche Bank

2020-11-18 09:25:00

AMZN

Amazon.com

$3,136.01 / +6.19 (+0.20%)

09:25

11/18/20

11/18

09:25

11/18/20

09:25

Jefferies software/pharma analysts hold analyst/industry conference call

Software & Internet Analyst Thill and Healthcare Analyst Tanquilut discuss Amazon's move into the Pharmaceuticals Industry on an Analyst/Industry conference call to be held on November 18 at 10 am.

18
Nov
18
Nov

AMZN Amazon.com

$3,136.01 / +6.19 (+0.20%)

11/18/20 Jefferies: Drug distributors' pullback on Amazon news an overreaction, says Jefferies

11/18/20 Bernstein: PBMs to feel pressure to add Amazon as in-network option, says Bernstein

11/18/20 RBC Capital: Walmart price target raised to $153 from $137 at RBC Capital

11/18/20 Deutsche Bank: GoodRx price target lowered to $31 from $50 at Deutsche Bank

TODAY'S FREE FLY STORIES

Upgrade	Barclays upgraded to Add from Sell at AlphaValue » 05:14 03/05/21 03/05 05:14 03/05/21 05:14 BCS Barclays $9.21 / -0.235 (-2.49%) AlphaValue upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays committed to medium-term targets, including RoTE of over 10% over time 02/18/21 Barclays sees 'meaningful' y/y RoTe improvement in 2021 02/18/21 Barclays declares 1.0p 2020 full year dividend 01/04/21 Penn National CFO David Williams steps down, Felicia Hendrix to succeed BCS Barclays $9.21 / -0.235 (-2.49%) 02/23/21 JPMorgan Barclays price target raised to 190 GBp from 180 GBp at JPMorgan 02/22/21 RBC Capital Barclays price target raised to 150 GBp from 140 GBp at RBC Capital 02/19/21 Deutsche Bank Barclays price target raised to 200 GBp from 180 GBp at Deutsche Bank 01/28/21 Berenberg Barclays price target raised to 180 GBp from 160 GBp at Berenberg BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays reports Q4 group profit before tax GBP0.6B vs. GBP1.1B last year 10/23/20 Barclays reports Q3 group profit before tax GBP 1.1B vs. GBP 0.2B last year 10/13/20 Fly Intel: What to watch in next round of big banks' earnings reports BCS Barclays $9.21 / -0.235 (-2.49%) 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says 02/18/21 Barclays CEO sees staff returning to office this year, Bloomberg reports 12/16/20 Barclays mulls raising bonus pool for traders by roughly 10%, Bloomberg says 10/01/20 Goldman Sachs to buy GM credit-card business for about $2.5B, WSJ reports BCS Barclays $9.21 / -0.235 (-2.49%) 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/01/20 Fly Intel: Wall Street's top stories for Thursday 09/11/20 The Intersection: Crypto and Wall Street This Week 03/25/21 REITwise 2021 Virtual Conference BCS Barclays $9.21 / -0.235 (-2.49%) 12/16/20 Barclays call volume above normal and directionally bullish 12/14/20 Unusual call flow in option market yesterday 12/11/20 Short-term premium buyer in Barclays 12/11/20 Unusually active option classes on open December 11th
Upgrade	Henkel upgraded to Hold from Sell at Nord/LB » 05:13 03/05/21 03/05 05:13 03/05/21 05:13 HENKY Henkel $0.00 / + (+0.00%) Nord/LB analyst Thorsten… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events HENKY Henkel $0.00 / + (+0.00%) 01/12/21 UBS Henkel price target raised to EUR 81 from EUR 80 at UBS 01/05/21 Barclays Barclays trims Henkel Adhesive estimates on slower recovery expectations 12/03/20 JPMorgan Henkel upgraded to Overweight from Neutral at JPMorgan 11/30/20 Commerzbank Henkel upgraded to Buy from Hold at Commerzbank 03/10/21 Global Consumer & Retail Virtual Conference 2021
Hot Stocks	Moderna announces Takeda NDA submission to distribute COVID-19 vaccine in Japan » 05:12 03/05/21 03/05 05:12 03/05/21 05:12 MRNA Moderna $132.21 / +1.01 (+0.77%) , TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) Moderna (MRNA) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/04/21 Moderna, IBM to collaborate on COVID vaccine supply, distribution data sharing 03/04/21 GC Pharma to support Moderna distribution of 40M doses of COVID-19 Vaccine 02/25/21 Moderna's chief medical officer Tal Zaks to leave company in late September 02/24/21 Moderna makes new capital investment to boost manufacturing capacity TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/26/21 Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham MRNA MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 03/16/21 31st Annual Healthcare Virtual Conference MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish
Recommendations	Costco price target lowered to $395 from $410 at Baird » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 COST Costco $319.35 / -4.53 (-1.40%) Baird analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Costco reports January SSS rose 15.9% 01/06/21 Costco December SSS, ex impact from gas, FX rose 10.9% 01/06/21 Costco December E-commerce sales ex gas, FX up 61.6% 11/24/20 Tinley Beverage Company completes full production at Long Beach facility COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Baird Costco January core comps re-accelerated, says Baird 02/02/21 Cleveland Research Costco U.S. sales slightly improved in January, says Cleveland Research 01/07/21 Deutsche Bank Costco price target raised to $347 from $344 at Deutsche Bank 01/06/21 Baird Costco saw some deceleration in December core comp sales, says Baird COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Costco reports Q2 EPS $2,14, consensus $2.44 03/04/21 Notable companies reporting after market close 12/10/20 Costco reports Q1 total company comparable sales up 15.4% 12/10/20 Costco reports Q1 EPS $2.62, consensus $2.05 COST Costco $319.35 / -4.53 (-1.40%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: After-Hours Movers COST Costco $319.35 / -4.53 (-1.40%) 12/10/20 Costco options imply 3.8% move in share price post-earnings 11/17/20 Early notable gainers among liquid option names on November 17th 09/24/20 Costco options imply 6.0% move in share price post-earnings 09/24/20 Unusually active option classes on open September 24th
Hot Stocks	Daqo signs three-year, 52,700 MT polysilicon supply agreement with Shangji » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 DQ Daqo New Energy $85.93 / -8.76 (-9.25%) Daqo New Energy announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events Options DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Daqo New Energy enters three-year polysilicon supply agreement with Zhonghuan 02/02/21 Daqo New Energy provides update on potential IPO in China 01/13/21 Daqo New Energy falls -6.4% 01/04/21 Daqo New Energy rises 16.1% DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Roth Capital Daqo New Energy price target raised to $115 from $105 at Roth Capital 02/08/21 Roth Capital Bill could be 'meaningful positive' for solar stocks, says Roth Capital 01/26/21 Roth Capital Daqo New Energy price target raised to $100 from $40 at Roth Capital 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 03/09/21 Daqo New Energy - DQ DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/25/21 Daqo New Energy call volume above normal and directionally bullish 01/11/21 Daqo New Energy put volume heavy and directionally bearish

Recommendations	Fulgent Genetics price target raised to $140 from $135 at Piper Sandler » 05:06 03/05/21 03/05 05:06 03/05/21 05:06 FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/16/21 Fulgent Genetics, BioIQ partner on COVID-19 testing programs 12/29/20 Fulgent Genetics extends partnership with NTC DOE and Health 12/17/20 PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program 11/18/20 Fulgent Genetics, LANES, LA DHS partner on COVID-19 testing FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/03/21 Piper Sandler Fulgent Genetics price target raised to $135 from $100 at Piper Sandler 02/01/21 Oppenheimer Fulgent Genetics price target raised to $130 from $75 at Oppenheimer 02/01/21 Oppenheimer Invitae downgraded to Perform on valuation at Oppenheimer 01/08/21 Credit Suisse Fulgent Genetics downgraded to Underperform from Neutral at Credit Suisse FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 03/04/21 Fulgent Genetics sees FY21 EPS $12.50, consensus $11.55 03/04/21 Fulgent Genetics reports Q4 EPS $6.20, consensus $4.05 11/23/20 Fulgent Genetics raises 2020 revenue view to at least $300M from $235M 11/09/20 Fulgent Genetics reports Q3 EPS$2.08 , consensus 55c FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 09/09/20 Report says U.S. may need 193M coronavirus tests per month, STAT reports FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 09/22/20 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 31st Annual Healthcare Virtual Conference
Recommendations	Alphatec price target raised to $19 from $17 at Piper Sandler » 05:05 03/05/21 03/05 05:05 03/05/21 05:05 ATEC Alphatec $15.86 / -0.69 (-4.17%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ATEC Alphatec $15.86 / -0.69 (-4.17%) 02/01/21 Alphatec relocates to new headquarters in Carlsbad 12/17/20 Alphatec to acquire EOS imaging for $79.7M in cash, sees accretion ATEC Alphatec $15.86 / -0.69 (-4.17%) 01/29/21 Piper Sandler Alphatec price target raised to $17 from $12 at Piper Sandler 01/12/21 Piper Sandler Piper remains buyer of Alphatec despite Covid pressures 12/21/20 H.C. Wainwright Alphatec price target raised to $16 from $12 at H.C. Wainwright 12/18/20 Lake Street Alphatec price target raised to $20 from $15 at Lake Street ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Alphatec reports Q4 EPS (35c), consensus (21c) 01/12/21 Alphatec sees 2021 revenue approximately $178M, consensus $183.08M 01/12/21 Alphatec sees 2020 revenue $144.8M-$145.1M, consensus $144.13M 01/12/21 Alphatec sees Q4 revenue $43.8M-$44.1M, consensus $43.66M 14 Oct ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers 10/08/20 Fly Intel: Wall Street's top stories for Thursday 03/08/21 Alphatec
Upgrade	Bombardier upgraded to Outperform from Market Perform at BMO Capital » 05:04 03/05/21 03/05 05:04 03/05/21 05:04 BDRBF Bombardier $0.00 / + (+0.00%) BMO Capital analyst Fadi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BDRBF Bombardier $0.00 / + (+0.00%) 03/04/21 Bombardier targets 2025 total revenues about $7.5B 03/04/21 Bombardier expects business jet deliveries to begin gradual recovery in 2021 03/03/21 Bombardier, Aston Martin sign LOI for custom design services on business jets 02/23/21 Bombardier reports suffering 'limited cybersecurity breach' BDRBF Bombardier $0.00 / + (+0.00%) 02/16/21 Cowen Bombardier downgraded to Underperform from Market Perform at Cowen 02/16/21 Scotiabank Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank 02/12/21 National Bank Bombardier price target lowered to C$0.70 from C$0.80 at National Bank 02/12/21 BMO Capital Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital BDRBF Bombardier $0.00 / + (+0.00%) 02/11/21 Bombardier reports Q4 cont ops EPS (1c), consensus 0c 02/11/21 Bombardier sees FY21 adjusted EBITDA greater than $500M BDRBF Bombardier $0.00 / + (+0.00%) 11/13/20 Disney upgrade among today's top calls on Wall Street 05/06/21 Bombardier - BDRBF
Recommendations	Cutera price target raised to $42 from $38 at Piper Sandler » 05:02 03/05/21 03/05 05:02 03/05/21 05:02 CUTR Cutera $26.21 / -8.715 (-24.96%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera not providing formal guidance at this time CUTR Cutera $26.21 / -8.715 (-24.96%) 02/18/21 Piper Sandler Cutera price target raised to $38 from $28 at Piper Sandler 11/05/20 Piper Sandler Cutera price target raised to $28 from $22 at Piper Sandler 09/14/20 Stephens Cutera price target raised to $24 from $18 at Stephens 08/07/20 Piper Sandler Cutera should be bought at these 'depressed levels,' says Piper Sandler CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera reports Q4 EPS 12c, consensus 4c 11/04/20 Cutera reports Q3 EPS (13c), consensus (33c) 17 Apr CUTR Cutera $26.21 / -8.715 (-24.96%) 11/04/20 Fly Intel: After-Hours Movers 03/18/21 Cutera
Upgrade	Fifth Third upgraded to Conviction Buy from Buy at Goldman Sachs » 05:00 03/05/21 03/05 05:00 03/05/21 05:00 FITB Fifth Third $35.57 / -0.36 (-1.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FITB Fifth Third $35.57 / -0.36 (-1.00%) 02/22/21 Fifth Third CEO Carmichael sells over 155,000 common shares 01/21/21 Fifth Third sees y/y adjusted positive operating leverage in 2H21 01/21/21 Fifth Third sees utilization to remain unchanged for 1H, up 1% in 2H 01/21/21 Fifth Third doesn't see growing investment portfolio in near-term FITB Fifth Third $35.57 / -0.36 (-1.00%) 02/17/21 Citi Citi recommends two new U.S. bank pair trades 01/27/21 Argus Fifth Third price target raised to $35 from $27 at Argus 01/22/21 Wedbush Fifth Third price target raised to $39 from $36 at Wedbush 01/22/21 RBC Capital Fifth Third price target raised to $32 from $27 at RBC Capital FITB Fifth Third $35.57 / -0.36 (-1.00%) 01/21/21 Fifth Third reports Q4 EPS 78c, consensus 69c 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open FITB Fifth Third $35.57 / -0.36 (-1.00%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says FITB Fifth Third $35.57 / -0.36 (-1.00%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 04/20/21 Fifth Third - FITB 04/13/21 Fifth Third Bancorp

Downgrade	Nikola downgraded to Neutral from Overweight at JPMorgan » 04:56 03/05/21 03/05 04:56 03/05/21 04:56 NKLA Nikola $16.04 / -0.49 (-2.96%) JPMorgan analyst Paul… JPMorgan analyst Paul Coster downgraded Nikola to Neutral from Overweight with a price target of $30, down from $33. Following the Q4 report, which provided investors reassurance that the company is "more focused," much of "good news is now priced in the stock," Coster tells investors in a research note. The analyst believes the story "should heat up again" in to mid- to late-2021 if customer orders get announced and as the first fuel cell electric vehicle prototype "comes to life." Coster calls the downgrade a "tactical call" based on the timing of catalysts. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola sees delivering first Nikola Tre BEVs to customers during Q4 02/25/21 Nikola CEO says 'necessary changes' made in Q4 to 'refocus and realign' company 02/23/21 Nikola provides update on North American hydrogen fuel-cell vehicle program 01/14/21 Worthington sells it remaining 7.05M shares of Nikola NKLA Nikola $16.04 / -0.49 (-2.96%) 02/01/21 Fly Intel: Top five analyst upgrades 02/01/21 Wedbush Nikola upgraded to Neutral from Underperform at Wedbush 12/28/20 JPMorgan JPMorgan cuts Nikola target but sees 'generally positive' news flow in 2021 12/24/20 Loop Capital Nikola faces 'another setback in a series of setbacks,' says Loop Capital NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola reports Q4 adjusted EPS (17c), consensus (23c) 02/25/21 Notable companies reporting after market close 11/09/20 Nikola reports Q3 adjusted EPS (16c), consensus (19c) 11/09/20 Notable companies reporting after market close NKLA Nikola $16.04 / -0.49 (-2.96%) 02/26/21 Nikola's review finds several of Milton's claims 'inaccurate,' FT reports 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close 02/16/21 Churchill Capital Corp IV near deal to bring Lucid Motors public, Reuters says 02/12/21 Nikola, APS electricity deal approved by state regulators, AZ Big Media says NKLA Nikola $16.04 / -0.49 (-2.96%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 03/19/21 Electric Truck Day NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola options imply 19.4% move in share price post-earnings 02/03/21 Nikola call volume above normal and directionally bullish 01/27/21 Nikola call volume above normal and directionally bullish 01/26/21 Nikola call volume above normal and directionally bullish
Conference/Events	SeaSpine management to meet virtually with BTIG » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 SPNE SeaSpine $17.86 / -0.69 (-3.72%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SPNE SeaSpine $17.86 / -0.69 (-3.72%) 03/01/21 SeaSpine sees 150-200bps of gross margin expansion in FY21 03/01/21 SeaSpine announces full commercial launch of Reef TO Interbody System 02/22/21 SeaSpine announces limited commercial launch of WaveForm system 01/20/21 SeaSpine announces limited commercial launch of Regatta Lateral Plate System SPNE SeaSpine $17.86 / -0.69 (-3.72%) 03/02/21 Canaccord SeaSpine price target raised to $25 from $23 at Canaccord 03/01/21 Piper Sandler SeaSpine price target raised to $28 from $22 at Piper Sandler 01/29/21 Piper Sandler SeaSpine price target raised to $22 from $18 at Piper Sandler 01/11/21 Piper Sandler SeaSpine should be bought on any weakness today, says Piper Sandler SPNE SeaSpine $17.86 / -0.69 (-3.72%) 03/01/21 SeaSpine reports Q4 EPS (37c), consensus (26c) 01/11/21 SeaSpine sees FY20 revenue $154.1M-$154.5M, consensus $155.18M 01/11/21 SeaSpine reports preliminary Q4 revenue $46.2M-$46.2M, consensus $47.27M 11/09/20 SeaSpine reports Q3 EPS (24c), consensus (31c) SPNE SeaSpine $17.86 / -0.69 (-3.72%) 10/19/20 Fly Intel: After-Hours Movers 00:00 Today SeaSpine 03/19/21 SeaSpine
Conference/Events	Zealand Pharma to host research and development virtual day » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) Research and Development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) 12/15/20 Zealand Pharma: Dasiglucagon did not meet primary endpoint in Phase 3 trial 12/15/20 Zealand Pharma announces data from Phase 3 dasiglucagon in CHI trial 11/20/20 Zealand Pharma increases share capital following exercise of employee warrants ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) 03/10/20 Morgan Stanley Zealand Pharma EPS estimates cut at Morgan Stanley ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) 11/12/20 Zealand Pharma expects 2020 revenue for V-Go sales DKK150M-DKK175M 11/12/20 Zealand Pharma reports Q3 revenue DKK56.5M vs. DKK9.9M last year 03/11/21 Zealand Pharma - ZEAL 03/27/21 PDFUA Date for Dasiglucagon HypoPal�Rescue Pen 10:00 Today Zealand Pharma
Conference/Events	FBN Securities to hold a virtual tour » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 SIRI Sirius XM $5.79 / -0.09 (-1.53%) , VIAC ViacomCBS $71.87 / +1.01 (+1.43%) , WWE WWE $52.57 / +0.74 (+1.43%) , FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) , BATRA Liberty Braves Group $29.93 / -1 (-3.23%) , LSXMA Liberty SiriusXM $43.38 / -0.99 (-2.23%) , LGF.A Lionsgate $17.09 / +0.32 (+1.91%) Media & Entertainment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SIRI VIAC WWE FWONA LSXMA LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/02/21 Sirius XM added 909,000 net new self-pay subscribers for FY20 02/02/21 Sirius XM says new car penetration reached approximately 80% in Q4 02/02/21 Sirius XM sees FY21 SiriusXM self-pay net subscriber additions of ~800,000 01/27/21 Sirius XM trading resumes VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 03/04/21 ViacomCBS launches Paramount+ 02/24/21 ViacomCBS unveils Streaming video strategy w/ slate of originals 02/24/21 ViacomCBS announces launch of Avatar Studios 02/24/21 ViacomCBS says new 'Rugrats' series coming to Paramount+ in 2021 WWE WWE $52.57 / +0.74 (+1.43%) 01/25/21 WWE, Peacock announce multi-year streaming agreement 01/25/21 WWE sees FY20 adjusted OIBDA approximately $286M 11/25/20 WWE names Karen Mullane as Controller & Chief Accounting Officer 11/20/20 WWE, Credit One Bank enter multi-year partnership FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) 09/25/20 Liberty Media announces Stefano Domenicali to assume role of CEO of Formula 1 LSXMA Liberty SiriusXM $43.38 / -0.99 (-2.23%) 09/25/20 Liberty Media announces Stefano Domenicali to assume role of CEO of Formula 1 LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 03/02/21 Lionsgate and STARZ close output deal 02/26/21 Lionsgate, Sony Pictures enter multi-year distribution agreement 12/22/20 Sony Pictures CEO says 'don't think' will move to 'day and date' film releases 12/02/20 Starz announces launch of direct to consumer 'Lionsgate Play' in India SIRI VIAC WWE FWONA BATRA LSXMA LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/03/21 Citi Tax sharing agreement 'very bullish' for Liberty SiriusXM, says Citi 01/28/21 Fly Intel: Top five analyst downgrades 01/28/21 Credit Suisse Sirius XM downgraded to Neutral after rally at Credit Suisse 01/27/21 Credit Suisse Sirius XM downgraded to Neutral from Outperform at Credit Suisse VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 03/01/21 Cowen ViacomCBS price target raised to $46 from $39 at Cowen 02/25/21 Fly Intel: Pre-market Movers 02/25/21 Loop Capital ViacomCBS cut to Sell at Loop Capital with profitability from streaming unclear 02/25/21 Needham ViacomCBS price target raised to $80 from $55 at Needham WWE WWE $52.57 / +0.74 (+1.43%) 02/05/21 Needham WWE price target raised to $65 from $50 at Needham 01/27/21 MKM Partners WWE price target raised to $65 from $60 at MKM Partners 01/26/21 Benchmark WWE price target raised to $62 from $55 at Benchmark 01/19/21 Evercore ISI Evercore ISI upgrades 'COVID recovery idea' WWE to Outperform FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) 03/04/21 Citi Liberty Formula One price target raised to $46 from $40 at Citi 12/10/20 Guggenheim Liberty Formula One initiated with a Buy at Guggenheim 11/11/20 Pivotal Research Liberty Formula One price target raised to $50 from $47 at Pivotal Research 10/01/20 Berenberg Liberty Formula One initiated with a Buy at Berenberg BATRA Liberty Braves Group $29.93 / -1 (-3.23%) LSXMA Liberty SiriusXM $43.38 / -0.99 (-2.23%) 02/03/21 Citi Tax sharing agreement 'very bullish' for Liberty SiriusXM, says Citi 01/11/21 Barclays Liberty SiriusXM upgraded to Overweight from Equal Weight at Barclays 12/17/20 Morgan Stanley Liberty SiriusXM price target raised to $52 from $45 at Morgan Stanley 11/19/20 Deutsche Bank Liberty SiriusXM price target raised to $69 from $64 at Deutsche Bank LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 02/08/21 Deutsche Bank Lionsgate price target raised to $16 from $12 at Deutsche Bank 02/05/21 RBC Capital Lionsgate price target raised to $13 from $7 at RBC Capital 01/28/21 Macquarie Lionsgate price target raised to $18 from $12 at Macquarie 11/10/20 Deutsche Bank Lionsgate price target raised to $12 from $10 at Deutsche Bank SIRI VIAC WWE FWONA LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/02/21 Sirius XM sees FY21 adjusted EBITDA approximately $2.575B 02/02/21 Sirius XM reports Q4 EPS (16c), consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 02/24/21 ViacomCBS reports Q4 EPS $1.04, consensus $1.02 02/24/21 Notable companies reporting after market close 11/06/20 ViacomCBS reports Q3 adj. EPS 91c, consensus 80c 11/05/20 Notable companies reporting before tomorrow's open WWE WWE $52.57 / +0.74 (+1.43%) 02/04/21 WWE reports Q4 adjusted EPS 24c, consensus 30c 10/29/20 WWE reports Q3 adjusted EPS 56c, consensus 38c FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) 02/26/21 Liberty Media reports Q4 revenue $485M, consensus $604.33M 11/05/20 Liberty Media reports Q3 EPS 6c, consensus (4c) LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 02/04/21 Lionsgate reports Q3 adjusted EPS 21c, consensus (11c) 11/05/20 Lionsgate reports Q2 adjusted EPS 33c, consensus (3c) 11/05/20 Notable companies reporting after market close 25 Mar SIRI VIAC WWE LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 01/15/21 Apple to challenge Spotify with podcast subscription service, Information says 10/06/20 Sirius XM close to contract renewal deal with Howard Stern, Bloomberg says VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 03/03/21 Amazon in talks to carry 'many' exclusive NFL games on Prime Video, WSJ says 02/11/21 ViacomCBS working on '60 Minutes' spinoff for Paramount+, Bloomberg says 02/01/21 Facebook hires Henry Moniz as chief compliance officer, BI reports 01/26/21 CBS suspends executives accused of creating hostile work environment, NYT says WWE WWE $52.57 / +0.74 (+1.43%) 11/20/20 WWE agrees to multi-year partnership deal with Credit One, Sportico reports LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 12/10/20 Disney, NBCUniversal unlikely to follow WarnerMedia's 2021 media plan, CNBC says 11/05/20 Lionsgate laying off about 15% of motion picture unit staff, Variety says SIRI VIAC WWE LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/02/21 Fly Intel: Pre-market Movers 01/27/21 Fly Intel: What to watch in Apple earnings report 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 02/04/21 Best Buy upgrade, ViacomCBS downgrade among today's top calls on Wall Street 01/28/21 Tesla downgrade, Twitter upgrade among today's top calls on Wall Street 01/27/21 Nokia soars but company 'not aware' of apparent reason for trading activity WWE WWE $52.57 / +0.74 (+1.43%) 02/04/21 Fly Intel: After-Hours Movers 01/25/21 Fly Intel: Pre-market Movers LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 11/05/20 Fly Intel: After-Hours Movers 10/04/20 Box Office Battle: 'Tenet' stays on top as box office recovery collapses 09/27/20 Box Office Battle: 'Tenet' stays on top, nears $300M globally 09/25/20 Box Office Battle: 'Tenet' expected to remain #1, other films delay openings 03/11/21 Media 00:00 Today Media & Entertainment Virtual Tour 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 04/28/21 Sirius XM - SIRI SIRI VIAC SIRI Sirius XM $5.79 / -0.09 (-1.53%) 03/04/21 Sirius XM call volume above normal and directionally bullish 01/25/21 Sirius XM call volume above normal and directionally bullish 01/05/21 Unusual call flow in option market yesterday 01/04/21 Sirius XM call volume above normal and directionally bullish VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 02/18/21 Early notable gainers among liquid option names on February 18th 02/04/21 ViacomCBS Class B put volume heavy and directionally bearish 12/14/20 ViacomCBS Class B put volume heavy and directionally bearish 12/11/20 ViacomCBS Class B call volume above normal and directionally bullish
Conference/Events	Pfizer management to meet virtually with Oppenheimer » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 PFE Pfizer $34.20 / -0.18 (-0.52%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $34.20 / -0.18 (-0.52%) 03/03/21 FDA expands approval of Pfizer's Lorbrena 03/02/21 Strata Oncology starts trial with Pfizer as partner 03/01/21 Flowserve supports Pfizer in production of COVID-19 vaccine 02/26/21 Pfizer: EMA accepts MAA for 20-valent pneumococcal conjugate vaccine candidate PFE Pfizer $34.20 / -0.18 (-0.52%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/03/21 Mizuho Pfizer price target lowered to $42 from $44 at Mizuho PFE Pfizer $34.20 / -0.18 (-0.52%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open PFE Pfizer $34.20 / -0.18 (-0.52%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/19/21 Pfizer to use additional capacity to boost vaccine output, Bloomberg says 02/19/21 BioNTech, Pfizer vaccine 85% effective after first dose, FT reports PFE Pfizer $34.20 / -0.18 (-0.52%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday 03/24/21 Arthritis Advisory Committee and Drug Safety & Risk Mgmt Committee Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 00:00 Today Pfizer PFE Pfizer $34.20 / -0.18 (-0.52%) 03/04/21 Pfizer call volume above normal and directionally bullish 01/29/21 Unusually active option classes on open January 29th 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th

Conference/Events	Oppenheimer medical tech analyst to hold an analyst/industry conference call » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 JNJ Johnson & Johnson $153.00 / -3.11 (-1.99%) , MDT Medtronic $115.10 / -2.82 (-2.39%) , ISRG Intuitive Surgical $709.48 / -18.36 (-2.52%) , TRXC TransEnterix / + Medical Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ MDT ISRG TRXC JNJ Johnson & Johnson $153.00 / -3.11 (-1.99%) 03/04/21 Nemaura Medical appoints Alistair Longmuir as advisor on manufacture strategy 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ MDT Medtronic $115.10 / -2.82 (-2.39%) 03/04/21 Medtronic announces first procedures in trial of PulseSelect System 03/02/21 Medtronic says new analysis of REVERSE trial shows CRT benefit for more patients 03/01/21 Medtronic recalls HVAD Pump Implant Kit over delayed, failed restart 02/23/21 Medtronic says new products driving share gains ISRG Intuitive Surgical $709.48 / -18.36 (-2.52%) 01/21/21 Intuitive Surgical says overall procedure growth was 6% in Q4 10/27/20 Intuitive Surgical launches $100M venture capital fund 10/15/20 Intuitive Surgical slides 2.8% to $720 per share after Q3 results 10/15/20 Intuitive Surgical's first 9 months of 2020 saw 'significant impact' from COVID TRXC TransEnterix / + 03/03/21 Asensus Surgical receives additional FDA clearance for Senhance Surgical System 02/23/21 TransEnterix announces name change to Asensus Surgical 02/18/21 TransEnterix announces new training center in EU 02/18/21 TransEnterix announces new training center in EU JNJ MDT ISRG TRXC JNJ Johnson & Johnson $153.00 / -3.11 (-1.99%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MDT Medtronic $115.10 / -2.82 (-2.39%) 02/24/21 Cowen Medtronic price target raised to $135 from $120 at Cowen 02/24/21 Stifel Medtronic price target raised to $135 after earnings at Stifel 02/23/21 Piper Sandler Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler ISRG Intuitive Surgical $709.48 / -18.36 (-2.52%) 01/22/21 JPMorgan Intuitive Surgical price target raised to $840 from $825 at JPMorgan 01/22/21 Raymond James Intuitive Surgical price target raised to $865 from $800 at Raymond James 01/22/21 Wells Fargo Intuitive Surgical price target raised to $879 from $841 at Wells Fargo 01/22/21 Oppenheimer Intuitive Surgical price target raised to $410 from $365 at Oppenheimer TRXC TransEnterix / + 01/20/21 Ladenburg TransEnterix downgraded to Neutral on valuation at Ladenburg 01/20/21 Ladenburg TransEnterix downgraded to Neutral from Buy at Ladenburg JNJ MDT ISRG TRXC JNJ Johnson & Johnson $153.00 / -3.11 (-1.99%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MDT Medtronic $115.10 / -2.82 (-2.39%) 02/23/21 Medtronic reports Q3 EPS $1.29, consensus $1.15 11/24/20 Medtronic reports Q2 EPS $1.02, consensus 80c 10/14/20 Medtronic sees long-term annual organic revenue growth of 5% ISRG Intuitive Surgical $709.48 / -18.36 (-2.52%) 01/21/21 Intuitive Surgical reports Q4 EPS $3.58, consensus $3.12 01/21/21 Notable companies reporting after market close 01/13/21 Intuitive Surgical sees 2020 revenue $4.36B, consensus $4.27B 01/13/21 Intuitive Surgical sees Q4 revenue $1.33B, consensus $1.23B TRXC TransEnterix / + 01/06/21 TransEnterix sees FY20 revenue $3.0M-$3.2M, consensus $3.11M 01/06/21 TransEnterix sees Q4 revenue $1.1M, consensus $1.04M JNJ MDT JNJ Johnson & Johnson $153.00 / -3.11 (-1.99%) 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports MDT Medtronic $115.10 / -2.82 (-2.39%) 10/01/20 DOJ opens ventilator antitrust probe with Medtronic focus, WSJ reports 09/30/20 DoJ opens ventilator antitrust probe with Medtronic focus, WSJ says JNJ MDT ISRG TRXC JNJ Johnson & Johnson $153.00 / -3.11 (-1.99%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday MDT Medtronic $115.10 / -2.82 (-2.39%) 10/08/20 Tesla upgrade, Citi downgrade among today's top calls on Wall Street ISRG Intuitive Surgical $709.48 / -18.36 (-2.52%) 01/21/21 Fly Intel: After-Hours Movers 10/15/20 Fly Intel: After-Hours Movers TRXC TransEnterix / + 03/03/21 Fly Intel: Pre-market Movers 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 10:00 Today Medical Technology 03/08/21 Biopharmaceuticals 03/11/21 TransEnterix - TRXC 04/20/21 Johnson & Johnson - JNJ 04/20/21 Intuitive Surgical - ISRG JNJ MDT ISRG TRXC JNJ Johnson & Johnson $153.00 / -3.11 (-1.99%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th MDT Medtronic $115.10 / -2.82 (-2.39%) 02/23/21 Early notable gainers among liquid option names on February 23rd 10/08/20 Unusually active option classes on open October 8th ISRG Intuitive Surgical $709.48 / -18.36 (-2.52%) 11/12/20 Early notable gainers among liquid option names on November 12th 10/15/20 Intuitive Surgical options imply 5.8% move in share price post-earnings TRXC TransEnterix / + 03/03/21 Unusually active option classes on open March 3rd 02/10/21 Largest borrow rate increases among liquid names 02/04/21 Largest borrow rate increases among liquid names 12/18/20 Largest borrow rate increases among liquid names
Conference/Events	Greenhill & Co. participates in a conference call with JMP Securities » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 GHL Greenhill & Co. $15.35 / -0.785 (-4.87%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GHL Greenhill & Co. $15.35 / -0.785 (-4.87%) 02/24/21 Greenhill & Co. CEO buys 33.1K shares of common stock 11/03/20 Greenhill & Co. falls -10.1% GHL Greenhill & Co. $15.35 / -0.785 (-4.87%) 02/05/21 JMP Securities Greenhill & Co. upgraded to Outperform from Market Perform at JMP Securities 11/03/20 Keefe Bruyette Greenhill downgraded to Underperform from Market Perform at Keefe Bruyette 10/09/20 Keefe Bruyette Greenhill & Co. upgraded to Market Perform from Underperform at Keefe Bruyette GHL Greenhill & Co. $15.35 / -0.785 (-4.87%) 02/04/21 Greenhill & Co. reports Q4 EPS $2.71, consensus $1.41 11/02/20 Greenhill & Co. reports Q3 EPS (49c), consensus (8c) 00:00 Today Greenhill & Co. - GHL
Conference/Events	Akoustis management to meet virtually with Piper Sandler » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 AKTS Akoustis $12.84 / -1.2 (-8.55%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AKTS Akoustis $12.84 / -1.2 (-8.55%) 03/03/21 Akoustis awarded design win for XBAW filters from CBRS customer 02/01/21 Akoustis locks process flow for wafer-level-chip-scale-package 01/29/21 Akoustis receives volume order for XBAW WiFi 6E filter solutions 12/16/20 Akoustis receives first 5G mobile orders for XBAW filters AKTS Akoustis $12.84 / -1.2 (-8.55%) 02/23/21 Roth Capital Akoustis equity financing improves balance sheet, says Roth Capital 02/02/21 Lake Street Akoustis price target raised to $19 from $10 at Lake Street 02/01/21 Roth Capital Akoustis price target raised to $25 from $16 at Roth Capital 01/28/21 Oppenheimer Akoustis price target raised to $20 from $15 at Oppenheimer AKTS Akoustis $12.84 / -1.2 (-8.55%) 02/01/21 Akoustis reports Q2 EPS (30c), consensus (23c) 11/02/20 Akoustis reports Q4 non-GAAP EPS (23c), consensus (24c) 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 00:00 Today Akoustis AKTS Akoustis $12.84 / -1.2 (-8.55%) 01/29/21 Akoustis options imply 10.9% move in share price post-earnings 01/07/21 Largest borrow rate increases among liquid names
Conference/Events	Ahold Delhaize management to meet virtually with Wolfe Research » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 ADRNY Ahold Delhaize $0.00 / + (+0.00%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events ADRNY Ahold Delhaize $0.00 / + (+0.00%) 11/18/20 Ahold Delhaize, Centerbridge Partners to buy FreshDirect, terms not disclosed ADRNY Ahold Delhaize $0.00 / + (+0.00%) 02/22/21 Morgan Stanley Ahold Delhaize price target lowered to EUR 23.70 from EUR 25.40 at Morgan Stanley 02/19/21 Credit Suisse Ahold Delhaize price target lowered to EUR 22 from EUR 24 at Credit Suisse 02/19/21 Berenberg Ahold Delhaize price target raised to EUR 22.90 from EUR 22.70 at Berenberg 01/20/21 Credit Suisse Ahold Delhaize price target lowered to EUR 24 from EUR 25 at Credit Suisse 00:00 Today Ahold Delhaize 03/08/21 Ahold Delhaize
Conference/Events	Citigroup to hold a virtual conference » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 SKM SK Telecom $24.24 / -0.43 (-1.74%) , SSNLF Samsung $0.00 / + (+0.00%) , HYMTF Hyundai Motor $0.00 / + (+0.00%) , LPL LG Display $9.75 / -0.2 (-2.01%) Korea Investor Virtual… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SKM SSNLF HYMTF LPL SKM SK Telecom $24.24 / -0.43 (-1.74%) 11/16/20 SK Telecom, Amazon to collaborate on new offering in Korea 10/14/20 SK Telecom falls -4.5% SSNLF Samsung $0.00 / + (+0.00%) 03/02/21 ITC to investigate certain cellular devices made by Samsung, Motorola Mobility 02/19/21 Solas OLED announces patent dispute settlement with LG Display 01/27/21 Samsung sees Memory business recovering during H1 01/17/21 Fly Intel: Top five weekend stock stories HYMTF Hyundai Motor $0.00 / + (+0.00%) 02/07/21 Fly Intel: Top five weekend stock stories 12/11/20 Hyundai Motor to acquire controlling interest in Boston Dynamics from SoftBank 12/11/20 Hyundai Motor to acquire 80% of Boston Dynamics from SoftBank 12/10/20 Hyundai Motor introduces HTWO fuel cell system brand LPL LG Display $9.75 / -0.2 (-2.01%) 02/19/21 Solas OLED announces patent dispute settlement with LG Display 12/15/20 LG Display rises 7.5% SKM SSNLF HYMTF LPL SKM SK Telecom $24.24 / -0.43 (-1.74%) 08/20/20 Goldman Sachs SK Telecom initiated with a Buy at Goldman Sachs SSNLF Samsung $0.00 / + (+0.00%) 02/04/21 Craig-Hallum Qorvo price target raised to $195 from $160 at Craig-Hallum 02/04/21 Craig-Hallum Digital Turbine price target raised to $80 from $60 at Craig-Hallum 01/29/21 Needham Skyworks price target raised to $245 from $200 at Needham 01/26/21 Applied Materials upgraded to Buy at DA Davidson on semicap strength HYMTF Hyundai Motor $0.00 / + (+0.00%) 03/04/21 Goldman Sachs Hyundai Motor initiated with a Buy at Goldman Sachs 02/09/21 Craig-Hallum Velodyne target cut to $29 at Craig-Hallum as 'lower visibility' reasons emerge 02/04/21 Wedbush Apple Car deal with Hyundai could be around the corner, says Wedbush LPL LG Display $9.75 / -0.2 (-2.01%) 01/28/21 JPMorgan LG Display upgraded to Overweight from Neutral at JPMorgan 01/27/21 Nomura LG Display downgraded to Neutral after 80% rally at Nomura 01/27/21 Nomura LG Display downgraded to Neutral from Buy at Nomura 09/21/20 Daiwa LG Display upgraded to Outperform from Hold at Daiwa SSNLF SSNLF Samsung $0.00 / + (+0.00%) 01/27/21 Samsung sees overall profit weakening in Q1 01/27/21 Samsung reports Q4 operating profit KRW9.05T 01/07/21 Samsung sees Q4 operating profit KRW9.00T vs. KRW9.52T consensus 10/28/20 Samsung reports Q3 operating profit KRW12.35T vs KRW7.78T last year SSNLF HYMTF SSNLF Samsung $0.00 / + (+0.00%) 03/04/21 Nintendo to unveil Switch model with bigger OLED display, Bloomberg says 03/03/21 Samsung eyes four sites in U.S. for new $17B chip plant, Reuters reports 02/17/21 Samsung, NXP, Infineon have power shut off in Austin, AAS reports 02/05/21 Samsung eyes Austin, Texas for new $17B chip plant, Reuters reports HYMTF Hyundai Motor $0.00 / + (+0.00%) 02/10/21 Edmunds says Teslas tested 'failed to hit' EPA range estimates 02/07/21 Hyundai, Kia say not in talks with Apple on autonomous car, Reuters reports 02/05/21 Apple-Hyundai car talks paused recently, Bloomberg says 02/03/21 Apple, Hyundai-Kia close to finalizing deal over Apple Car, CNBC reports SSNLF HYMTF SSNLF Samsung $0.00 / + (+0.00%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: What to watch in Qualcomm's earnings report 01/21/21 Fly Intel: What to watch in Intel's earnings report HYMTF Hyundai Motor $0.00 / + (+0.00%) 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday

Conference/Events	Altimmune management to meet virtually with Piper Sandler » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 ALT Altimmune $13.20 / -1.11 (-7.76%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options ALT Altimmune $13.20 / -1.11 (-7.76%) 02/25/21 Altimmune commences enrollment in AdCOVID Phase 1 clinical trial 02/17/21 Altimmune announces FDA clearance of AdCOVID IND application 12/30/20 Altimmune begins Phase 2 trial of HepTcell for chronic hepatitis B 12/23/20 Altimmune announces clinical hold on AdCOVID IND application by FDA ALT Altimmune $13.20 / -1.11 (-7.76%) 02/18/21 B. Riley Securities Altimmune price target raised to $41 from $28 at B. Riley Securities 02/17/21 Piper Sandler Piper remains bullish on Altimmune after FDA clears Covid vaccine trial 02/10/21 Guggenheim Altimmune initiated with a Buy at Guggenheim 12/30/20 Piper Sandler 2021 is the 'breakout year' for Altimmune, says Piper Sandler ALT Altimmune $13.20 / -1.11 (-7.76%) 02/25/21 Altimmune reports FY20 EPS ($1.91), consensus ($2.59) 14 Jul ALT Altimmune $13.20 / -1.11 (-7.76%) 12/24/20 Fly Intel: Wall Street's top stories for Thursday 12/24/20 Fly Intel: Pre-market Movers 12/23/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: Wall Street's top stories for Monday 03/15/21 33rd Annual Roth Virtual Conference 00:00 Today Altimmune ALT Altimmune $13.20 / -1.11 (-7.76%) 10/23/20 Largest borrow rate increases among liquid names 09/30/20 Largest borrow rate increases among liquid names
Conference/Events	Cowen Internet & restaurants analysts to hold analyst/industry conference call » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 GRUB GrubHub $59.19 / -2.6 (-4.21%) , UBER Uber $53.07 / -3.04 (-5.42%) Internet & New Media… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options GRUB UBER GRUB GrubHub $59.19 / -2.6 (-4.21%) 02/03/21 GrubHub reports Q4 active diners 31.4M, up 39% 01/14/21 GrubHub names Devry Boughner Vorwerk as Chief Corporate Affairs Officer 01/13/21 GrubHub falls -5.5% 01/11/21 Lear partners with GrubHub to deliver ordering capabilities in FCA vehicles UBER Uber $53.07 / -3.04 (-5.42%) 02/26/21 EVgo says partnering to offer savings for EV drivers on Uber's platform 02/19/21 Uber to launch 'nationwide consultation' in UK after Supreme Court ruling 02/19/21 Uber drops 3% to $57.10 after U.K. Supreme Court rejects appeal 02/19/21 U.K. Supreme Court rejects Uber appeal, says drivers are workers GRUB UBER GRUB GrubHub $59.19 / -2.6 (-4.21%) 01/04/21 Barclays GrubHub assumed with an Equal Weight at Barclays 10/16/20 HSBC HSBC upgrades Just Eat Takeaway.com to Buy on continued execution 08/28/20 Piper Sandler Piper 'bearishly inclined' on Uber, Lyft shares into November election 08/13/20 DA Davidson GrubHub price target raised to $79 from $63 at DA Davidson UBER Uber $53.07 / -3.04 (-5.42%) 02/22/21 Loop Capital Airbnb upgraded to Buy from Hold at Loop Capital 02/17/21 Argus Uber price target raised to $73 from $63 at Argus 02/16/21 JMP Securities Uber price target raised to $75 from $58 at JMP Securities 02/12/21 DA Davidson Uber price target raised to $72 from $49 at DA Davidson GRUB UBER GRUB GrubHub $59.19 / -2.6 (-4.21%) 02/03/21 GrubHub reports Q4 adjusted EPS (41c), consensus 5c 02/03/21 Notable companies reporting after market close 10/28/20 GrubHub reports Q3 non-GAAP EPS 16c, consensus (9c) UBER Uber $53.07 / -3.04 (-5.42%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/10/21 Uber reports Q4 EPS (54c), consensus (55c) 02/10/21 Notable companies reporting after market close 01/25/21 Fly Intel: What to watch in credit card space earnings reports 08 Jan GRUB UBER GRUB GrubHub $59.19 / -2.6 (-4.21%) 10/27/20 Suit claims Grubhub added eateries to platform without consent, Bloomberg says UBER Uber $53.07 / -3.04 (-5.42%) 03/02/21 Uber spinning out delivery robot operation into startup, Bloomberg reports 02/26/21 Uber-backed Lime in early talks to go public via a SPAC, BI reports 02/24/21 China's Didi Chuxing plans to make debut in Western Europe, Bloomberg says 02/18/21 Uber pushes 'work from home policy' out till mid-September, Tech Crunch reports GRUB UBER GRUB GrubHub $59.19 / -2.6 (-4.21%) 02/03/21 Fly Intel: After-Hours Movers UBER Uber $53.07 / -3.04 (-5.42%) 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/12/21 The Intersection: Crypto and Wall Street This Week 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 12:00 Today Internet & New Media/Restaurants 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference UBER UBER Uber $53.07 / -3.04 (-5.42%) 02/25/21 Uber call volume above normal and directionally bullish 02/10/21 Uber options imply 11.7% move in share price post-earnings 01/11/21 Uber call volume above normal and directionally bullish 01/07/21 Uber call volume above normal and directionally bullish
Conference/Events	OceanFirst Financial management to meet virtually with DA Davidson » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 OCFC OceanFirst Financial $22.45 / -0.44 (-1.92%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OCFC OceanFirst Financial $22.45 / -0.44 (-1.92%) 09/24/20 OceanFirst Financial appoints Patricia Turner to board of directors OCFC OceanFirst Financial $22.45 / -0.44 (-1.92%) 02/01/21 Boenning & Scattergood Boenning & Scattergood upgrades OceanFirst to Outperform after earnings 02/01/21 Boenning & Scattergood OceanFirst Financial upgraded to Outperform from Neutral at Boenning & Scattergood 12/17/20 DA Davidson DA Davidson boosts OceanFirst to Buy, calls it a Top Pick for 2021 12/17/20 DA Davidson OceanFirst Financial upgraded to Buy from Neutral at DA Davidson OCFC OceanFirst Financial $22.45 / -0.44 (-1.92%) 01/28/21 OceanFirst Financial reports Q 4EPS 39c consensus 38c 10/29/20 OceanFirst Financial reports Q3 core EPS 0c, consensus 41c 00:00 Today OceanFirst Financial
Conference/Events	Premier Financial management to meet virtually with Piper Sandler » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 PFC Premier Financial $31.12 / -0.82 (-2.57%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PFC Premier Financial $31.12 / -0.82 (-2.57%) 01/26/21 Premier Financial increases share buyback authorization to up to 2M shares 01/26/21 Premier Financial raises quarterly dividend 9.1% to 25c per share 01/26/21 Premier Financial's Gary Small to become CEO on April 1, 2021 PFC Premier Financial $31.12 / -0.82 (-2.57%) 01/27/21 Keefe Bruyette Keefe Bruyette says time to buy Premier Financial, ups target to $34 12/28/20 Piper Sandler Premier Financial price target lowered to $25.50 from $26.50 at Piper Sandler PFC Premier Financial $31.12 / -0.82 (-2.57%) 01/26/21 Premier Financial reports Q4 EPS ex-items 87c, consensus 69c 10/20/20 Premier Financial reports Q3 ex-items EPS 69c, consensus 59c 00:00 Today Premier Financial
Conference/Events	Sykes Enterprises management to meet virtually with Barrington » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 SYKE Sykes Enterprises $41.79 / -0.11 (-0.26%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SYKE Sykes Enterprises $41.79 / -0.11 (-0.26%) 12/21/20 Sykes Enterprises acquires The Penny Hoarder for $102.5M 11/16/20 NICE, Symphony partner to expand deployment of robotic process automation 10/08/20 Sykes Enterprises appoints David Brain as CDO SYKE Sykes Enterprises $41.79 / -0.11 (-0.26%) 02/25/21 Barrington Sykes Enterprises price target raised to $48 from $46 at Barrington 01/06/21 Barrington Imax and Sirius XM among Barrington's best ideas for 2021 11/06/20 Barrington Sykes Enterprises upgraded to Outperform from Market Perform at Barrington 09/22/20 Baird Sykes Enterprises desiganted as a Fresh Pick at Baird SYKE Sykes Enterprises $41.79 / -0.11 (-0.26%) 02/23/21 Sykes Enterprises reports Q4 EPS 81c, consensus 78c 11/04/20 Sykes Enterprises sees FY20 EPS $2.65-$2.68, consensus $2.45 11/04/20 Sykes Enterprises sees Q4 EPS 75c-79c, consensus 70c 11/04/20 Sykes Enterprises reports Q3 EPS 76c, consensus 55c 00:00 Today Sykes Enterprises

Events

Earnings calls, analyst events, roadshows and more

COE
Today at 08:00

China Online Education - COE Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
CLLS
Today at 08:00

Cellectis - CLLS Conference Calls
EGLE
Today at 08:00

Eagle Bulk Shipping - EGLE Conference Calls
GSX
Today at 08:00

GSX Techedu - GSX Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
Today at 08:00

European Capital Goods Industry Meetings
Today at 08:30

International Trade in Goods Balance: January 2021 Government Event
Today at 08:30

Manufacturing Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Participation Rate: February 2021 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair $44.00-46.25 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Jefferies software/pharma analysts hold analyst/industry conference call

TODAY'S FREE FLY STORIES

Get Full Fly Access